Annual Work Programmes

• 2023 Work Programme
• 2022 Work Programme
• 2021  Work Programme

The topics, numbered from PJ-01 to PJ-08, focus among others on innovative approaches to cancer screening, non-communicable diseases (NCDs), mental health, health technology and workforce.

The total budget amounts to €107.3 million

• EU4H-2022-PJ-01 – Call for proposals to monitor and strengthen the implementation of innovative approaches to prostate, lung and gastric cancer screening at Union level
• EU4H-2022-PJ-02 – Call for proposals on prevention of NCDs – other NCDs (different from cardiovascular diseases and diabetes)
• EU4H-2022-PJ-03 – Call for proposals on promoting mental health
• EU4H-2022-PJ-04 – Call for proposals to support the implementation of the Regulation on health technology assessment – training of patient and clinical experts contributing to joint health technology assessment activities
• EU4H-2022-PJ-05 – Call for proposals to support increased capacity of notified bodies for medical devices
• EU4H-2022-PJ-06 – Call for proposals to provide training for health workforce, including digital skills
• EU4H-2022-PJ-07 – Call for proposals to support Member States and other relevant actors to implement relevant results of innovative public health research in relation to vaccination against COVID-19
• EU4H-2022-PJ-08 – Call for proposals to develop early warning features and guidance in the area of pricing through the EURIPID database, based on competition cases

There are nine Joint Actions (JA) 2022, covering the following areas:

• Implementation of AMR measures in Member States (pages 13 -15) – Budget: 50.000.000 €
• Cancer and other NCDs prevention – action on health determinants (pages 18 -20) – Budget: 75.000.000 €
• Prevention of NCDs – cardiovascular diseases and diabetes (pages 21 – 22) – Budget: 55.000.000 €
• Contribution to the Cancer Inequalities Registry to monitor national cancer control policies (pages 54-56) – Budget: 1.000.000 €
• Support ERNs integration to the national healthcare systems of Member States (pages 62 – 63) – Budget:11.200.000 €
• Increasing capacity building of the EU medicines regulatory network (pages 68 – 69) – Budget: 8.000.000 €
• Piloting a new model approach for assessing and authorising novel Blood, Tissues and Cells (BTC) preparation processes (pages 70 – 71) – Budget: 1.500.000 €
• Reinforced market surveillance of medical devices and in vitro medical devices (pages 72 – 74) – Budget: 4.000.000 €
• Preparatory actions for a European Health Data Space; primary use of data (for healthcare) and reuse of data (pages 81 – 82) – Budget: 4.000.000 €

Co-financing takes place through a direct grant procedure, i.e. without the publication of a notice. Therefore, to participate in a JA it is necessary to be designated by the competent authority of the EU Member State.

Total budget of 43.850.000 €:

• EU4H-2021-PJ-06 – Action grants for developing a pilot project for an EU infrastructure ecosystem for the secondary use of health data for research, policy-making and regulatory purposes
• EU4H-2021-PJ-07 – Action grants to support implementation of best practices on the ground with direct impact on the effort to tackle mental health challenges during COVID-19
• EU4H-2021-PJ-08 – Action grants to support actions to improve access to human papillomavirus vaccination
• EU4H-2021-PJ-09 – Action grants for the initiative ‘HealthyLifestyle4All’: promotion of healthy lifestyles
• EU4H-2021-PJ-10 – Action grants to reduce liver and gastric cancers caused by infections
• EU4H-2021-PJ-11 – Action grants for ‘EU Cancer Treatment Capacity and Capability Mapping’ project – Network of Comprehensive Cancer Centres
• EU4H-2021-PJ-12 – Action grants to create a ‘Cancer Survivor Smart Card’
• EU4H-2021-PJ-13 – Action grants to support the implementation of best practices in community-based services for the human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS), tuberculosis, viral hepatitis and sexually transmitted infections
• EU4H-2021-PJ-14 – Action grants supporting training activities, implementation, and best practices
• EU4H-2021-PJ-15 – Action grants for ‘Cancer Diagnostic and Treatment for All’ including ‘Genomic for Public Health’
• EU4H-2021-PJ-16 – Action grants for the Computer-aided Drug Repurposing for Cancer Therapy Project
• EU4H-2021-PJ-17 – Action grants to organise and collect data to understand the safety, quality and efficacy of therapies applied in the field of assisted reproduction and based on haematopoietic stem cells
• EU4H-2021-PJ-18 – Action grants boosting cancer prevention through the use of the European Code against Cancer and other concerted actions